Form 4: Precipio Director Granted Stock Options

Precipio, Inc. director David Seth Cohen was granted 1,500 stock options with an exercise price of $23.82 per share, vesting monthly over one year.

Summary

• David Seth Cohen, a Director of Precipio, Inc. (PRPO), was granted 1,500 stock options.
• The transaction date for this grant was January 2, 2026.
• The stock options have an exercise price of $23.82 per share.
• These options will vest in twelve equal monthly installments, beginning on the one-month anniversary of the issuance date.
• The options were granted pursuant to Precipio's Equity Incentive Plan as consideration for Mr. Cohen's service as a director.
• The expiration date for these stock options is January 2, 2036.

Sentiment

Score: 7

Explanation: The grant of stock options to a director is a positive step for aligning management and shareholder interests, reflecting continued commitment. It is a routine compensation event, not indicative of significant new operational or financial news, hence a moderately positive score.

Positives

• The grant of stock options aligns the director's financial interests with those of the shareholders, incentivizing long-term company performance.
• The compensation is part of an existing Equity Incentive Plan, indicating a structured approach to executive and director remuneration.

Negatives

• Potential for future dilution of existing shares if the options are exercised, although the number of shares is relatively small.

Risks

• The value of the stock options is dependent on the future market price of Precipio's common stock, which is subject to market volatility and company performance.
• Exercise of options could lead to a slight dilution of existing shareholder equity.

Future Outlook

The grant of stock options suggests the continued service of David Seth Cohen as a director and aims to incentivize his long-term commitment and contribution to Precipio's performance.

Management Comments

• The stock option was granted pursuant to the Issuer's Equity Incentive Plan in consideration for the Reporting Person's service as a director of the Issuer.

Industry Context

Granting stock options to directors is a common practice across various industries, particularly in publicly traded companies, to align the interests of board members with those of shareholders and to serve as a form of long-term incentive compensation.

Comparison to Industry Standards

• The practice of granting stock options to directors is a standard component of compensation packages in many U.S. public companies, including those in the biotechnology and diagnostics sectors like Precipio.
• This aligns with corporate governance best practices that seek to tie director compensation to company performance and shareholder value creation, similar to companies such as Exact Sciences (EXAS) or Guardant Health (GH) which utilize equity-based compensation for their board members.

Corporate Governance

Related Party Transactions

• The grant of stock options to David Seth Cohen, a director, constitutes a related party transaction as it involves compensation to a member of the company's board.

Stakeholder Impact

• Shareholders: Potential for long-term benefit from aligned director incentives, balanced against minor potential future dilution upon option exercise.
• Directors: Provides equity-based compensation, linking personal financial outcomes to company performance.

Next Steps

• The granted options will vest in twelve equal monthly installments, starting one month after the issuance date of January 2, 2026.

Key Dates

Recommendation

This Form 4 reports a routine grant of stock options to a director as part of their compensation, which is a standard practice to align interests. It does not present new material information that would warrant a change in investment recommendation, thus maintaining a 'hold' stance.

Keywords

Precipio, PRPO, Stock Options, Director Compensation, Equity Incentive Plan, SEC Form 4, Insider Transaction, Corporate Governance